Astellas Pharma, Inc Company Profile and Facts –


Pune, Maharashtra, India, October 10, 2022 (Wiredrelease) Prudour Pvt. Ltd-:Astellas Pharma, Inc. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. The company was founded in April 1953 and has since become one of the largest pharmaceutical companies in Japan. Astellas Pharma’s primary focus is the research and development of new drugs and treatments for various diseases and conditions. The company also manufactures and markets over-the-counter drugs, medical devices and dietary supplements. Astellas Pharma employs more than 17,000 people worldwide and does business in more than 50 countries. In 2015, the company generated sales of over 1 trillion yen ($8.3 billion). Astellas Pharma is a member of the Nikkei 225 stock index and is listed on the Tokyo Stock Exchange. Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments Report includes Company Description, Revenue (Million US$), Operating Income (Million US$), Net Income (millions of US dollars), SWOT analysis, detailed reports on mergers and acquisitions (M&A), divestitures, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Astellas Pharma, Inc Company – Mergers and acquisitions (M&A), partnerships and alliances

Key financial data
Revenue (millions of US dollars)

US$11,257 million was the annual revenue generated by Astellas Pharma, Inc. in 2021

Astellas Pharma, Inc.’s 2020 annual revenue was US$11,583 million, down -1.28% from 2019

Compared to 2018 annual revenue, Astellas Pharma, Inc. recorded a decline of -4.55% in 2019, amounting to US$11,734 million

Total sales of US$12,293 million were generated in 2018 by Astellas Pharma, Inc.

Buy this full company profile-


This report includes Astellas Pharma, Inc Company – Mergers & Acquisitions (M&A), Partnerships & Alliance contact information and business summary, tables, charts, list of partners and targets, breakdown of financial and legal advisors , deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of corporate partners, targets, investors and suppliers, if any.

The profile also includes detailed reports on all mergers and acquisitions, private equity, public offering, venture financing, partnership and divestiture transactions undertaken by the company Astellas Pharma, Inc – Mergers and Acquisitions (M&A ), partnerships and alliances. These transaction reports contain information about the target company’s finances, funding sources, method of payment, transaction values, and advisors of various parties, if any.

Reasons to buy

– Access comprehensive data on financial transactions as well as charts and graphs covering mergers and acquisitions, private equity, partnerships and alliances.

– Form an independent opinion on Astellas Pharma, Inc Company’s growth strategies – Mergers & Acquisitions (M&A), Partnerships & Alliances across organic and inorganic businesses.

– Track your competitor’s business structure and growth strategies.

For exclusive information-




Mergers and Acquisitions – Deal Reports


Corporate Venturing – Transaction Reports


Partnership – Transaction Reports


Capital Raising – Overview

Capital Raising – Transaction Reports

Divestments – Transaction Reports

Related report information:

Global Anti-Infective Agents Market:

Global Histoplasmosis Treatment Market:

Global market for immunosuppressive drugs for organ transplants:

Global drug reuse market:

Global Cardiovascular Drugs Market:

Global Pertussis Vaccine Market:

Global ibuprofen market:

This content was posted by Prudour Pvt. company ltd. WiredRelease’s news service was not involved in the creation of this content. For press release service inquiries, please contact us at [email protected]


Comments are closed.